# SUCRALFATE
> **ANDA217126** · Abbreviated New Drug Application (Generic) · Sponsor: COSETTE · Approved 2024-11-13
## Drug
- **FDA Application Number:** ANDA217126
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SUCRALFATE
- **Generic name:** SUCRALFATE
- **Active ingredients:** SUCRALFATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** COSETTE
- **Manufacturer:** Cosette Pharmaceuticals, Inc.
- **First approval:** 2024-11-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217126)
---
*MORVS · CC0 1.0*